Intra-cellular therapies highlights data presentations at the american college of neuropsychopharmacology annual meeting

Company presents positive results of a pre-specified patient population in study 403 examining the effects of caplyta® (lumateperone) in patients experiencing a major depressive episode with anxious distress and mixed features.
ITCI Ratings Summary
ITCI Quant Ranking